NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free IBB Stock Alerts $128.72 +2.61 (+2.07%) (As of 02:52 PM ET) Add Compare Share Share Today's Range$126.59▼$128.8850-Day Range$124.64▼$140.8952-Week Range$111.83▼$141.16Volume1.22 million shsAverage Volume1.80 million shsMarket Capitalization$7.15 billionAssets Under Management$7.00 billionDividend Yield0.32%Net Expense Ratio0.44% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media Get iShares Biotechnology ETF alerts: Email Address About iShares Biotechnology ETF (NASDAQ:IBB)iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More IBB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBB ETF News HeadlinesApril 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2?The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.April 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2? (IBB)The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gainsApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 19, 2024 | msn.com9 Best Biotech ETFs for 2024April 17, 2024 | nasdaq.comIBB Crosses Critical Technical IndicatorApril 10, 2024 | msn.comTop 10 best performing S&P 500 health care stocks of 2024April 8, 2024 | investing.comSemiconductors Steady, Biotech Stumbles: What's Next for These Sectors?April 2, 2024 | investing.comYields Up, US Dollar Up, Junk Bonds Tumble as New Quarter Kicks OffApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 1, 2024 | seekingalpha.comPBE: Biotech Could Be Next Big WinnerSee More Headlines Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings224 Fund Statistics Assets Under Management$7.00 billion Average Daily Volume$1.52 million Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume5,717 Put Options2,830 Call Options2,887 Short Interest8,740,000 shs Miscellaneous Outstanding Shares55,550,000Beta0.73 Creation Unit50,000 Creation Fee$614.00 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.44%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.44%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.44%0.60%0.60%0.54%0.58% iShares Biotechnology ETF (IBB) Holdings & ExposureTop 10 IBB HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.54%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.32%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.23%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.17%IQVIA(NYSE:IQV)Holding Weight: 4.42%Moderna(NASDAQ:MRNA)Holding Weight: 3.71%Biogen(NASDAQ:BIIB)Holding Weight: 2.98%Mettler-Toledo International(NYSE:MTD)Holding Weight: 2.73%Illumina(NASDAQ:ILMN)Holding Weight: 2.00%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 1.97%IBB Sector ExposureIBB Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesSimilar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipRaymond James Financial Services Advisors Inc.Bought 20,533 shares on 4/23/2024Ownership: 0.314%Fifth Third BancorpSold 154 shares on 4/23/2024Ownership: 0.025%Principle Wealth Partners LLCSold 114 shares on 4/23/2024Ownership: 0.011%Tyche Wealth Partners LLCSold 171 shares on 4/23/2024Ownership: 0.010%Hanson & Doremus Investment ManagementSold 103 shares on 4/23/2024Ownership: 0.007%View All Institutional Transactions IBB ETF - Frequently Asked Questions How have IBB shares performed in 2024? iShares Biotechnology ETF's stock was trading at $135.85 on January 1st, 2024. Since then, IBB stock has decreased by 5.3% and is now trading at $128.65. View the best growth stocks for 2024 here. How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF? iShares Biotechnology ETF declared a quarterly dividend on Wednesday, March 20th. Stockholders of record on Friday, March 22nd will be paid a dividend of $0.126 per share on Wednesday, March 27th. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Thursday, March 21st. Read our dividend analysis for IBB. What does IBB invest in? iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.00 billion assets under management. What stocks does iShares Biotechnology ETF hold? IBB invests in 224 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), IQVIA (IQV), Moderna (MRNA), Biogen (BIIB), Mettler-Toledo International (MTD), Illumina (ILMN) and Alnylam Pharmaceuticals (ALNY). What is the management fee for iShares Biotechnology ETF? iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%. When did iShares Biotechnology ETF's stock split? Shares of iShares Biotechnology ETF split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL). Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Global Assets Advisory LLC (0.87%), Raymond James & Associates (0.33%), Raymond James Financial Services Advisors Inc. (0.31%), Albion Financial Group UT (0.23%), Cumberland Advisors Inc. (0.15%) and Appleton Partners Inc. MA (0.13%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBB) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.